Pelabresib,Ruxolitinib
morphosys
['$mor', 'morphosys']
$mor morphosys presents multiple analyses of the manifest phase 2 trial investigating the potential of pelabresib in the treatment of myelofibrosis at eha 2022 45 seconds delayed.
Democratizing insights.

Not investment advice.